Peripheral neuropathy decisions — 2025

The Board denied earlier effective dates for the awards of separate 20 percent ratings for right and left lower extremity femoral nerve diabetic peripheral neuropathy, as well as a rating in excess of 20 percent for diabetes mellitus.

The Board denied service connection for all the claimed conditions as there was no evidence to support a causal relationship between any of the claimed conditions and the Veteran's active military service.

The Board remanded all issues related to service connection for various disabilities, including heart disability and peripheral neuropathies. The Veteran's claims are being sent back for additional development.

The Board denied the veteran's request for an earlier effective date for a 40 percent rating increase for peripheral neuropathy in both lower extremities, stating that the symptoms did not worsen before August 13, 2018.

The Board remanded the veteran's claims for service connection for various conditions, including PTSD and peripheral neuropathy, due to conflicting medical evidence and the need for further examination.

The Board remanded the case to determine if the veteran's diabetes and related conditions are service-connected earlier than August 10, 2022. The decision is based on potential herbicide exposure in Guam.

The Board denied service connection for left foot hammer toes, left foot neuropathy, and right foot neuropathy as secondary to a low back disability due to lack of current diagnosis and impairment of earning capacity.

The Veteran's claim for a total disability rating based on individual unemployability (TDIU) is granted. The Board found that the Veteran is unable to obtain or maintain gainful employment due to his service-connected disabilities.

The Veteran's request for a higher rate of special monthly compensation (SMC) was denied because the evidence did not show loss of use of either hand or foot.

The Board granted effective dates of May 28, 2014, for the awards of service connection for POEMS syndrome and related neuropathies.

The Board denied service connection for bilateral upper and lower extremity neuropathy, but granted SMC based on the need for regular aid and attendance due to the Veteran's service-connected disabilities.

The Board dismissed the veteran's claims for service connection for various disabilities due to an untimely appeal.

The Veteran's right lower extremity peripheral neuropathy involving the sciatic nerve was granted an initial evaluation of 20 percent disabling, but no higher. Other claims for increased ratings were denied.

The Board granted service connection for a back disorder and remanded the other claims, including those for increased ratings and additional service connection.

The Board denied higher ratings for PTSD, diabetes mellitus type II with erectile dysfunction, and diabetic peripheral neuropathy in the right and left lower extremities. A compensable rating was also denied for chronic renal disease with hypertension.

The Board denied service connection for bilateral peripheral neuropathy of the upper and lower extremities, finding no evidence that the conditions were incurred in or aggravated by active duty.

The Board denied the Veteran's claims for an earlier effective date and initial ratings in excess of 20 percent for sciatic neuropathy, left and right lower extremities.

The veteran's service connection for prostate cancer, diabetes, and peripheral neuropathy in both legs was granted on a direct basis. The effective date for these conditions was set prior to August 10, 2022.

The Board remanded the Veteran's claims for service connection for a back disorder and peripheral neuropathy in both upper and lower extremities due to inadequate medical opinions. The Veteran will receive further evaluations.

The Board denied higher ratings for the veteran's diabetic peripheral neuropathy but remanded the issue of special monthly compensation (SMC) based on the need for aid and attendance.